Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 21 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Beisol Pharma Neerijse from Lubbeek, company number BE0544653020, closed financial year 2025 with a result of € 9,274 after tax. For that financial year Beisol Pharma Neerijse recorded revenue of € 18,180 and equity of € -47,301. Compared with financial year 2024, the result moved from € -161 to € 9,274. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 21, 2025.
€ -47,301
▲ € 9,274 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,274
▲ still € 161 loss in 2024
Profit after tax over the fiscal year.
€ 205
▲ € 199 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -53,501.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 5,250
Supplier invoices still open on the last day of the fiscal year.
€ 578
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 20,705 | € 40,905 | € 54,540 | € 18,180 | ▼ 67% |
| Gross margin | € 17,910 | € 25,537 | € 46,559 | € 9,691 | ▼ 79% |
| Profit after taxes | € -29,414 | € -22,432 | € -161 | € 9,274 | ▲ € 9,435 |
| Equity | € -33,982 | € -56,414 | € -56,575 | € -47,301 | ▲ € 9,274 |
| Total debts | € 191,465 | € 190,352 | € 170,045 | € 149,481 | ▼ 12% |
| Cash | - | € 123 | € 6 | € 205 | ▲ € 199 |
| Retained profit | € -40,182 | € -62,614 | € -62,775 | € -53,501 | ▲ € 9,274 |
| Balance sheet total | € 157,483 | € 133,938 | € 113,470 | € 102,180 | ▼ 10% |
Key figures of Beisol Pharma Neerijse, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to Beisol Pharma Neerijse?
What happened at Beisol Pharma Neerijse in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,274. Source: NBB ↗
- New establishment in Lubbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 29,414 loss in 2022 to € 9,274 profit in 2025.
Best year ever: 2025, with € 9,274 profit.
A new publication or filing at Beisol Pharma Neerijse? We notify you, reason included.
Follow Beisol Pharma NeerijseDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Staatsbaan(LUB) 187
3210 Lubbeek
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 8 companies are registered at this address.
All companies at this address →KULAPRO
€ 2.7 million revenue · 2025
CRAYNWINKEL
€ 366,044 revenue · 2025
Beisol Pharma Tienen
€ 11,200 revenue · 2025
Beisol Pharma Kortenberg
€ 26,900 revenue · 2025
Beisol Pharma Meerle
€ 20,480 revenue · 2025
+3 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0544.653.020
- VAT number
- BE 0544.653.020
- Registered office
- Staatsbaan(LUB) 187, 3210 Lubbeek
- Names & denominations
- Beisol Pharma Neerijse
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 January 2014
- Peppol
- Active · Active since 19 Dec 2025
- Contact
- [email protected] 016622141
- Activities · NACE
Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht